May 07, 2026
One of the clearest signs of a credible IV therapy clinic is that it tells you when not to proceed. At ALIV's Pune and Mumbai clinics, the clinical assessment before any first session is not a formality — it is where contraindications are identified before they become adverse events. Here is the honest guide to who should approach IV therapy with caution, who needs specialist clearance, and who should defer it altogether.
Your kidneys are responsible for excreting excess water-soluble vitamins, minerals, and the additional fluid load that every IV infusion adds. In patients with chronic kidney disease (CKD), this filtration capacity is reduced. A standard IV infusion adds 250–500mL of fluid to the circulatory system. In a functioning body, this is handled effortlessly. In a compromised renal system, it can contribute to fluid overload — a serious condition in which excess fluid accumulates in the lungs and body tissues.
Beyond fluid volume: high concentrations of potassium, magnesium, and phosphate — components of many IV formulations — can accumulate to dangerous levels in patients who cannot excrete them efficiently. This does not mean IV therapy is impossible for every CKD patient. It means formulations must be carefully selected, volumes strictly limited, and patients closely monitored. A nephrologist's clearance is essential before any IV programme begins in this population. The same careful evaluation applies to anyone with a single functioning kidney or a history of recent acute kidney injury.
Patients with congestive heart failure, significant valvular disease, or poorly controlled hypertension may not tolerate even moderate additional fluid volumes. The heart in these conditions is already working at or near capacity; an extra 300–500mL of intravenous fluid can be enough to tip the balance. IV therapy is not categorically contraindicated in all cardiac patients — but it requires conservative volumes, controlled infusion rates, pre-session blood pressure assessment, and active monitoring throughout.
Standard wellness IV formulations designed for healthy adults are not appropriate for patients with significant cardiac dysfunction without clinical modification. If you have a cardiac condition, disclose it fully at your ALIV assessment. The formulation and monitoring protocol will be adjusted accordingly. See our article on IV therapy and high blood pressure for the specific considerations for hypertensive patients.
Elective IV wellness therapy during pregnancy is not appropriate. Formulations designed for non-pregnant adults have not been studied for foetal safety, and the first trimester in particular is the period of maximum developmental vulnerability. IV therapy — including hydration and nutritional support — is administered during pregnancy in hospital settings for specific medical indications, under direct obstetric supervision. This is a different context entirely from elective wellness IV.
If you are pregnant, planning to become pregnant, or think you may be pregnant, disclose this before any IV session at ALIV. Our clinical team in Pune and Mumbai will advise on what, if anything, is appropriate for your situation — and when it would be appropriate to revisit IV therapy after delivery or after the first trimester, where relevant.
Intravenous access during an active infection creates a theoretical route for bacteria to enter the bloodstream through the IV site. While this risk is managed through rigorous sterile technique, elective IV therapy during active fever, known infection, or any acute illness is deferred until you have recovered. This is a straightforward clinical principle: IV therapy is a supportive intervention for people who are stable, not an emergency treatment for people who are acutely unwell.
If you arrive for a scheduled session feeling unwell — fever, significant new symptoms, or simply very different from your normal state — tell the nursing team before the session begins. Rescheduling is not an inconvenience. It is the clinically correct decision.
Patients with documented abnormalities in sodium, potassium, or calcium levels require careful assessment before receiving formulations containing these minerals. Adding an intravenous mineral load on top of an existing electrolyte imbalance can worsen the abnormality with real clinical consequences. This is why ALIV requires recent blood work before initiating any IV programme — not as bureaucratic process, but as the foundation of safe prescribing. Read our guide on which blood tests are needed before IV therapy.
Anticoagulants (blood thinners), diuretics, and certain antihypertensives can interact with IV formulations or affect how the body handles additional fluid and mineral loads. Disclose all medications — including over-the-counter drugs, supplements, and herbal preparations — at your clinical assessment. This is how safe IV therapy is practised.
Can I have IV therapy if I have diabetes?
Many patients with diabetes receive IV therapy safely at ALIV's Pune and Mumbai clinics. The key modifications: glucose-free carrier fluids (normal saline rather than dextrose), blood sugar monitoring before and after the session, and careful selection of ingredients that interact with insulin metabolism. Patients with insulin-dependent diabetes are advised to consult their treating physician before starting an IV programme. Our dedicated guide covers this fully: IV therapy safety for people with diabetes.
What happens if I don't disclose a health condition before my IV session?
The risk is yours. An undisclosed kidney condition with a high-volume infusion, or an undisclosed cardiac condition with a potassium-heavy formulation, can have serious consequences. At ALIV, health history is reviewed at every point of assessment — not as a formality, but because your safety depends on complete information. No clinical question asked by our team is unnecessary.
Is IV therapy safe after surgery?
Post-surgical IV therapy for nutritional recovery support is often appropriate — but timing and formulation must be determined by your surgeon and ALIV's clinical team in coordination. As a general principle, IV therapy is deferred until surgical wounds are healing without complication and there is no active infection risk at the site.
Can I have IV therapy if I am breastfeeding?
Breastfeeding is a different consideration from pregnancy. Many IV therapy formulations — B vitamins, vitamin C, magnesium — are safe during breastfeeding and may be beneficial for postpartum nutrient restoration. However, the full formulation must be reviewed by your ALIV doctor with breastfeeding status disclosed. Certain higher-dose antioxidants and herbal IV additives are not appropriate during breastfeeding. Disclose and discuss — do not assume either way.
What if I have a history of fainting from needles?
A history of vasovagal syncope (fainting) with blood draws or needle procedures is not a contraindication to IV therapy, but it is important clinical information. At ALIV, patients with this history are cannulated in a reclined position, monitored carefully during and after insertion, and allowed to rest before the infusion begins. Communicate this history at your pre-session assessment — it changes how the procedure is managed, not whether it happens.
Not sure whether a health condition makes IV therapy appropriate for you?
At ALIV in Pune and Mumbai, every patient undergoes a proper clinical assessment before any IV session is scheduled. We will tell you clearly if IV therapy is not the right step for your current health status. Visit alivtherapy.in to begin.
Medically Reviewed by Dr. Sunita Tandulwadkar. This article is for informational purposes only and does not constitute medical advice. Therapies offered by ALIV are proprietary, experimental protocols and results vary by individual.